Major histocompatibility complex HLA region largely explains the genetic variance exercised on neutrophil membrane proteinase 3 expression

Journal of the American Society of Nephrology

Volumn 17, Issue 11, 2006, Pages 3185-3191

  Von Vietinghoff, Sibylle ^a,d   Busjahn, Andreas ^c   Schönemann, Constanze ^b   Massenkeil, Gero ^b   Otto, Björn ^a   Luft, Friedrich C ^a   Kettritz, Ralph ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HealthTwist GmbH   (Germany)

^d NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOBLASTIN;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; GENETIC VARIABILITY; HLA SYSTEM; HLA TYPING; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONOZYGOTIC TWINS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEGENER GRANULOMATOSIS;

EID: 33750734363     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006050522     Document Type: Article

References (42)

1. Rarok AA, Stegeman CA, Limburg PC, Kallenberg CG: Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 13: 2232-2238, 2002
2. Schreiber A, Busjahn A, Luft FC, Kettritz R: Membrane expression of proteinase 3 is genetically determined. J Am Soc Nephrol 14: 68-75, 2003
3. Witko-Sarsat V, Lesavre P, Lopez S, Bessou G, Hieblot C, Prum B, Noel LH, Guillevin L, Ravaud P, Sermet-Gaudelus I, Timsit J, Grunfeld JP, Halbwachs-Mecarelli L: A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 10: 1224-1233, 1999
4. Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M: Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the -564 A/G promotor polymorphism. Clin Exp Immunol 145: 63-70, 2006
5. Buhaescu I, Covic A, Levy J: Systemic vasculitis: Still a challenging disease. Am J Kidney Dis 46: 173-185, 2005
6. Hay EM, Beaman M, Ralston AJ, Ackrill P, Bernstein RM, Holt PJ: Wegener's granulomatosis occurring in siblings. Br J Rheumatol 30: 144-145, 1991
7. Knudsen BB, Joergensen T, Munch-Jensen B: Wegener's granulomatosis in a family. A short report. Sound J Rheumatol 17: 225-227, 1988
8. Muniain MA, Moreno JC, Gonzalez Campora R: Wegener's granulomatosis in two sisters. Ann Rheum Dis 45: 417-421, 1986
9. Nowack R, Lehmann H, Flores-Suarez LF, Nanhou A, van der Woude FJ: Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis. Am J Kidney Dis 34: 364-373, 1999
10. Manganelli P, Giacosa R, Fietta P, Zanetti A, Neri TM: Familial vasculitides: Churg-Strauss syndrome and Wegener's granulomatosis in 2 first-degree relatives. J Rheumatol 30: 618-621, 2003
11. Spencer SJ, Burns A, Gaskin G, Pusey CD, Rees AJ: HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int 41: 1059-1063, 1992
12. Katz P, Alling DW, Haynes BF, Fauci AS: Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol 14: 268-270, 1979
13. Shankarkumar U, Ghosh K, Pradhan VD, Badakere SS, Mohanty D: Immunogenetic association in patients with antineutrophil cytoplasmic antibodies (ANCA) from Mumbai, Maharashtra, India. J Autoimmun 24: 227-233, 2005
14. Boki KA, Dafni U, Karpouzas GA, Papasteriades C, Drosos AA, Moutsopoulos HM: Necrotizing vasculitis in Greece: Clinical, immunological and immunogenetic aspects. A study of 66 patients. Br J Rheumatol 36: 1059-1066, 1997
15. Elkon KB, Sutherland DC, Rees AJ, Hughes GR, Batchelor JR: HLA antigen frequencies in systemic vasculitis: Increase in HLA-DR2 in Wegener's granulomatosis. Arthritis Rheum 26: 102-105, 1983
16. Gencik M, Meiler S, Borgmann S, Fricke H: Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 58: 2473-2477, 2000
17. Hagen EC, Stegeman CA, D'Amaro J, Schreuder GM, Lems SP, Tervaert JW, de Jong GM, Hene RJ, Kallenberg CG, Daha MR, et al.: Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis. Kidney Int 48: 801-805, 1995
18. Papiha SS, Murty GE, Ad'Hia A, Mains BT, Venning M: Association of Wegener's granulomatosis with HLA antigens and other genetic markers. Ann Rheum Dis 51: 246-248, 1992
19. Thomson JB, Hulse D, Galbraith I, McKay IC, Field M: Autoantibody associations with MHC class II antigens in scleroderma and autoimmune vasculitis. Autoimmunity 19: 265-269, 1994
20. Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, Tokunaga K, Hashimoto H: Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Association of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol 30: 1534-1540, 2003
21. Cotch MF, Fauci AS, Hoffman GS: HLA typing in patients with Wegener granulomatosis. Ann Intern Med 122: 635, 1995
22. Murty GE, Mains BT, Middleton D, Maxwell AP, Savage DA: HLA antigen frequencies and Wegener's granulomatosis. Clin Otolaryngol Allied Sci 16: 448-451, 1991
23. Strimlan CV, Taswell HF, Kueppers F, DeRemee RA, McDonald TJ: HLA-A antigens of patients with Wegener's granulomatosis. Tissue Antigens 11: 129-131, 1978
24. Griffith ME, Pusey CD: HLA genes in ANCA-associated vasculitides. Exp Clin Immunogenet 14: 196-205, 1997
25. Fietta P: Systemic vasculitides: Immunogenetics and familial clustering. Clin Exp Rheumatol 22: 238-251, 2004
26. Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B, Gross WL, Epplen JT: The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 52: 4039-4043, 2005
27. Rihova Z, Honsova E, Zavada J, Vankova Z, Jancova E, Reiterova J, Tesar V: Two familial cases of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Rheumatology (Oxford) 45: 356-357, 2006
28. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994
29. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr, et al: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33: 1101-1107, 1990
30. Heymann GA, Lassahn A, Schonemann C, Salama A: A novel HLA-A*680104 variant. Tissue Antigens 67: 169-170, 2006
31. Schreiber A, Otto B, Ju X, Zenke M, Goebel U, Luft FC, Kettritz R: Membrane proteinase 3 expression in patients with Wegener's granulomatosis and in human hematopoietic stem cell-derived neutrophils. J Am Soc Nephrol 16: 2216-2224, 2005
32. Lynn DL, Thomas A, Best N, Spiegelhalter D: WinBUGS: A Bayesian modelling framework: Concepts, structure, and extensibility. Stat Comput 10: 325-337, 2000
33. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
34. Cordell HJ, Clayton DG: Genetic association studies. Lancet 366: 1121-1131, 2005
35. Borgmann S, Haubitz M: Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Clin Exp Rheumatol 22[Suppl 36]: S79-S86, 2004
36. Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, Gross WL, Epplen JT: New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 114: 468-477, 2004
37. Szyld P, Jagiello P, Csernok E, Gross WL, Epplen JT: On the Wegener granulomatosis associated region on chromosome 6p21.3. BMC Med Genet 7: 21, 2006
38. Spriewald BM, Witzke O, Wassmuth R, Wenzel RR, Arnold ML, Philipp T, Kalden JR: Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis. Ann Rheum Dis 64: 457-461, 2005
39. Zhou Y, Giscombe R, Huang D, Lefvert AK: Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene. J Rheumatol 29: 317-320, 2002
40. Mascher B, Schmitt W, Csernok E, Tatsis E, Reil A, Gross WL, Seyfarth M: Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosis. Exp Clin Immunogenet 14: 226-233, 1997
41. Barrett J, Rezvani K: Neutrophil granule proteins as targets of leukemia-specific immune responses. Curr Opin Hematol 13: 15-20, 2006
42. Molldrem JJ, Lee PP, Kant S, Wieder E, Jiang W, Lu S, Wang C, Davis MM: Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J Clin Invest 111: 639-647, 2003